Sector: Health Care
Director information for EXACT SCIENCES CORP (data for year 2025)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Daniel Levangie | Former Chief Executive Officer and President of Cytyc Health Corporation; Currently Co-founder and Manager of ATON Partners and Chairman, President and Chief Executive Officer of CereVasc; Independent Director | 74 | ["Extensive expertise in all stages of product pipeline development", "Executive leadership roles overseeing commercialization, sales and marketing, operations and talent management", "Proven track record in in vitro diagnostics and medical devices fields", "Expertise in product development and commercialization", "Significant executive leadership from roles leading medical device and in vitro diagnostics companies"] | ["Audit and Finance", "Human Capital"] | 2025 |
| D. Scott Coward | Former Chief Legal Officer, Secretary, General Counsel, and Chief Administrative Officer of Exact Sciences Corporation; Non-Independent Director | 60 | ["Decades of legal experience working with large corporations and emerging growth healthcare companies", "Extensive legal and healthcare industry expertise", "Experience as Chief Legal Officer, Executive Vice President, General Counsel", "Managed legal teams at large public and early-stage growth companies", "Expertise in diagnostics, medical device and technology", "Understanding of corporate governance and sustainability", "Experience in finance, corporate strategy, and M&A", "Advising life sciences companies", "Adjunct professor of business law since 2023"] | ["Innovation", "Technology and Pipeline", "Innovation, Technology and Pipeline Committee"] | 2025 |
| Everett Cunningham | Former Chief Commercial Officer | [] | [] | 2025 | |
| James Doyle | Former Governor of Wisconsin; Currently Of Counsel at Foley & Lardner LLP and Partner of Doyle & Boyce Strategies; Independent Director | 79 | ["Extensive leadership experience as the 44th Governor of Wisconsin", "Skilled lawyer with expertise in complex legal challenges", "Significant government, regulatory, and compliance experience", "Worked closely with policy makers in the healthcare industry", "Experience with the White House and multi-state legislative efforts", "Proven executive leadership and talent management skills"] | ["Human Capital", "Corporate Governance and Nominating"] | 2025 |
| Jeffrey Elliott | Former Executive Vice President and Chief Financial Officer | [] | [] | 2025 | |
| Katherine Zanotti | Former Chief Executive Officer of Arbonne International; Independent Director | 70 | ["Over four decades of health and personal care industry expertise", "Executive leadership experience", "Successfully executed on international omni-channel growth initiatives", "Expertise in finance, corporate strategy, and M&A", "Former Chief Executive Officer of Arbonne International", "Senior Vice President of Marketing at McDonald's Corporation", "Vice President and General Manager at Procter & Gamble"] | ["Human Capital (Chair)"] | 2025 |
| Kevin Conroy | President, Chief Executive Officer, and Chairman of the Board of Directors of Exact Sciences Corporation; Chairman, President and Chief Executive Officer | 59 | ["Extensive business knowledge", "Legal and executive leadership experience", "20 years in the healthcare and health technology space", "Chief Executive Officer of Exact Sciences and Third Wave Technologies", "Experience in developing diagnostic tests", "Collaborative research efforts leading to the development of Cologuard"] | [] | 2025 |
| Kimberly Popovits | Former President and Chief Executive Officer of Genomic Health, Inc. and Advisor to the Coalition for 21st Century Medicine; Nominee | 66 | ["Over 40 years of experience in the healthcare industry", "President and Chief Executive Officer of Genomic Health, Inc. (2009-2019)", "Chief Operating Officer of Genomic Health (2002-2009)", "Chairman of the Board of Genomic Health (2012-2019)", "Senior Vice President, Marketing and Sales at Genentech, Inc. (2001-2002)", "Vice President, Sales at Genentech, Inc. (1994-2001)", "Interim Chief Executive Officer for Talis Biomedical Corporation in 2021"] | ["Human Capital", "Innovation, Technology & Pipeline", "Innovation, Technology and Pipeline Committee"] | 2025 |
| Leslie Trigg | President, Chief Executive Officer, and Chair of Outset Medical, Inc.; Chairman of the Board | 54 | ["Over 25 years of experience in leadership within the healthcare and medical device industries", "Expertise in cultivating relationships with shareholders and investors", "Knowledge in developing strong governance practices", "High-level strategic decision-making", "Experience in developing strategy and commercial infrastructure", "Leadership experience from previous board roles", "Background in communications and marketing"] | [] | 2025 |
| Michael Barber | Former Chief Diversity Officer of General Electric Company and former President and CEO of GE Molecular Imaging and Computed Tomography; Independent Director; Chair | 64 | ["Over 40 years of experience in executive roles at General Electric Company", "Healthcare industry leader with a track record in launching transformational technologies", "Significant global operational insights from experience at pharmaceutical and healthcare companies", "Chief Diversity Officer at GE", "Executive leadership experience across multiple product lines at GE"] | ["Audit and Finance", "Innovation, Technology & Pipeline", "Innovation, Technology and Pipeline Committee"] | 2025 |
| Paul Clancy | Former Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals, Inc.; Independent Director | 63 | ["Over 30 years of experience in financial management and strategic business planning", "Financial leadership in the biopharmaceutical and biotechnology industries", "Experience in strategic planning, financial management, capital allocation, mergers and acquisitions, business development and investor relations", "Former Chief Financial Officer of Alexion Pharmaceuticals, Inc. and Biogen Inc.", "Risk management expertise from board directs at public life sciences companies"] | ["Audit and Finance", "Corporate Governance and Nominating"] | 2025 |
| Shacey Petrovic | Former President and Chief Executive Officer of Insulet Corporation; Independent Director | 51 | ["Decades of experience in the medical device industry", "Executive Leadership", "Pipeline Development/Commercialization", "Sales and marketing experience", "Government, Regulatory, and Compliance", "Talent Management", "Finance, Corporate Strategy, and M&A"] | ["Corporate Governance and Nominating"] | 2025 |
